Future Studies and Implications for Dupilumab in Atopic Dermatitis

Future studies are necessary to continue evaluating the true benefits of dupilumab in conditions like atopic dermatitis.

Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.

Dr. Lio discussed how this approach has been different than previous studies about atopic dermatitis/conjunctivitis and future studies that are needed for dupilumab.